MARKET

ERNA

ERNA

Eterna Therapeutics Inc
NASDAQ
3.300
+0.020
+0.61%
After Hours: 3.390 +0.09 +2.73% 16:46 11/25 EST
OPEN
3.220
PREV CLOSE
3.280
HIGH
3.380
LOW
3.203
VOLUME
2.18K
TURNOVER
0
52 WEEK HIGH
132.00
52 WEEK LOW
2.735
MARKET CAP
9.71M
P/E (TTM)
-0.3148
1D
5D
1M
3M
1Y
5Y
Eterna Therapeutics On Nov. 23 Entered Securities Purchase Agreement Providing For Private Placement To Purchasers Of 2,184,950 Units
Benzinga · 2d ago
BRIEF-Eterna Therapeutics Inc - Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq On Nov 22
Reuters · 4d ago
Eterna Therapeutics Gets Non-Compliance Notice from Nasdaq
Eterna Therapeutics Gets Non-Compliance Notice from Nasdaq
MT Newswires · 4d ago
Eterna Therapeutics Announces Research Collaboration To Develop Advanced Gene-Edited iPS Cell Therapies
Benzinga · 11/01 12:33
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
Benzinga · 10/24 09:37
IceCure, Intuitive Surgical top healthcare gainers; EQRx, Denali among losers
Seekingalpha · 10/19 14:00
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Kintara Therapeutics (NASDAQ:KTRA) shares moved upwards by 74.8% to $0.17 during Wednesday's pre-market session. The company's market cap stands at $14.1 million.
Benzinga · 10/19 12:48
Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday.
Benzinga · 10/19 09:10
More
About ERNA
Eterna Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing advanced therapies using Messenger RNA (mRNA) cell engineering technology. The Company is engaged in developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its product pipeline is based on patented foundational mRNA cell engineering technology and offers multiple clinical applications with future sub-licensing and partnering opportunities. It formulates mRNA using lipid nanoparticle (LNP) technology. The ToRNAdo delivery system surrounds and protects the mRNA cargo, enabling delivery into human cells. The Company has licensed a portfolio of over 100 patents covering key cell engineering technologies, including therapeutic gene editing in clinical development. It has multiple cell and gene-editing therapies in preclinical development for various indications.

Webull offers kinds of Eterna Therapeutics Inc stock information, including NASDAQ:ERNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERNA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ERNA stock methods without spending real money on the virtual paper trading platform.